PPAR-δ Agonist MBX-8025 Abolishes Lipotoxicity and Reverses NASH in Diabetic Obese Mice

被引：0
|
作者：
Haczeyni, Fahrettin [1 ]
Wang, Hans [1 ]
Barn, Vanessa [1 ]
Mridha, Auvro R. [1 ]
Yeh, Matthew M. [2 ]
Haigh, W. G. [3 ]
Ioannou, George N. [3 ]
Choi, Yun-Jung [4 ]
McWerther, Charles [4 ]
Teoh, Narci C. [1 ]
Farrell, Geoffrey C. [1 ]
机构：
[1] Australian Natl Univ, Liver Res Grp, Sch Med, Canberra, ACT, Australia
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, VA Med Ctr, Seattle, WA USA
[4] CymaBay Therapeut Inc, Newark, CA USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
245
引用
收藏
页码：129A / 129A
页数：1
相关论文
共 22 条
  • [1] Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
    Choi, Yun-Jung
    Roberts, Brian K.
    Wang, Xueyan
    Geaney, J. Casey
    Naim, Sue
    Wojnoonski, Kathleen
    Karpf, David B.
    Krauss, Ronald M.
    [J]. ATHEROSCLEROSIS, 2012, 220 (02) : 470 - 476
  • [2] Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
    Jones, David
    Boudes, Pol F.
    Swain, Mark G.
    Bowlus, Christopher L.
    Galambos, Michael R.
    Bacon, Bruce R.
    Doerffel, Yvonne
    Gitlin, Norman
    Gordon, Stuart C.
    Odin, Joseph A.
    Sheridan, David
    Woerns, Markus-Alexander
    Clark, Virginia
    Corless, Linsey
    Hartmann, Heinz
    Jonas, Mark E.
    Kremer, Andreas E.
    Mells, George F.
    Buggisch, Peter
    Freilich, Bradley L.
    Levy, Cynthia
    Vierling, John M.
    Bernstein, David E.
    Hartleb, Marek
    Janczewska, Ewa
    Rochling, Fedja
    Shah, Hemant
    Shiffman, Mitchell L.
    Smith, John H.
    Choi, Yun-Jung
    Steinberg, Alexandra
    Varga, Monika
    Chera, Harinder
    Martin, Robert
    McWherter, Charles A.
    Hirschfield, Gideon M.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (10): : 716 - 726
  • [3] Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
    Van Rooyen, Derrick M.
    Gan, Lay T.
    Yeh, Matthew M.
    Haigh, W. Geoffrey
    Larter, Claire Z.
    Ioannou, George
    Teoh, Narci C.
    Farrell, Geoffrey C.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 144 - 152
  • [4] The Effects of a PPARα Agonist on Myocardial Damage in Obese Diabetic Mice With Heart Failure
    Chen, Rui
    Liang, Fengxia
    Morimoto, Shigeto
    Li, Qian
    Moriya, Junji
    Yamakawa, Jun-ichi
    Takahashi, Takashi
    Iwai, Kunimitsu
    Kanda, Tsugiyasu
    [J]. INTERNATIONAL HEART JOURNAL, 2010, 51 (03) : 199 - 206
  • [5] The Selective Peroxisome Proliferator-Activated Receptor-Delta Agonist Seladelpar Reverses Nonalcoholic Steatohepatitis Pathology by Abrogating Lipotoxicity in Diabetic Obese Mice
    Haczeyni, Fahrettin
    Wang, Hans
    Barn, Vanessa
    Mridha, Auvro R.
    Yeh, Matthew M.
    Haigh, W. Geoffrey
    Ioannou, George N.
    Choi, Yun-Jung
    McWherter, Charles A.
    Teoh, Narcissus C. -H.
    Farrell, Geoffrey C.
    [J]. HEPATOLOGY COMMUNICATIONS, 2017, 1 (07) : 663 - 674
  • [6] The PPAR-gamma agonist, pioglitazone, reverses neuropathic pain behavior in the obese Zucker Diabetic Fatty Rat
    Donahue, Renee Rivas
    Garrett, Colleen
    Taylor, Bradley
    [J]. FASEB JOURNAL, 2009, 23
  • [7] PPAR- agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice
    Rachid, Tamiris Lima
    Penna-de-Carvalho, Aline
    Bringhenti, Isabele
    Aguila, Marcia Barbosa
    Mandarim-de-Lacerda, Carlos Alberto
    Souza-Mello, Vanessa
    [J]. CELL BIOCHEMISTRY AND FUNCTION, 2015, 33 (04) : 249 - 256
  • [8] The effect of PPAR-γ agonist on glucose metabolism and insulin sensitivity in non-obese type 2 diabetic rat models
    Kim, Mi Jin
    Chung, Coon Hee
    [J]. DIABETES, 2006, 55 : A483 - A483
  • [9] The effect of rosiglitazone, an anti-diabetic PPAR-γ agonist, on bone mass and architecture in growing, adult, and aged mice
    Lecka-Czernik, B
    Lazarenko, OP
    Rzonca, SO
    Teng, K
    Suva, LJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S355 - S355
  • [10] Bavachinin, as a novel natural pan-PPAR agonist, exhibits unique synergistic effects with synthetic PPAR-γ and PPAR-α agonists on carbohydrate and lipid metabolism in db/db and diet-induced obese mice
    Li Feng
    Huan Luo
    Zhijian Xu
    Zhuo Yang
    Guoxin Du
    Yu Zhang
    Lijing Yu
    Kaifeng Hu
    Weiliang Zhu
    Qingchun Tong
    Kaixian Chen
    Fujiang Guo
    Cheng Huang
    Yiming Li
    [J]. Diabetologia, 2016, 59 : 1276 - 1286
123